HMGB2 and astrocytoma (excluding glioblastoma): 3.2. Spatial Heterogeneity of Diffuse Astrocytomas Was Associated with Dysregulation of Specific Molecular Pathways and HMGB2 Was Identified as a Putative Driver of Tumor Progression